Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -38.13x is 830% below its 5-year average of -4.10x, near the low end of its 5-year range (-38.13x–0.21x).
733.24% below its 12-month average of -4.58x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -8.44x.
INTEREST COVERAGE RATIO
-38.13x
INTEREST COVERAGE RATIO AVG TTM
-4.58x
INTEREST COVERAGE RATIO AVG 3Y
-2.85x
INTEREST COVERAGE RATIO AVG 5Y
-4.10x
INTEREST COVERAGE RATIO AVG 10Y
-4.35x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-733.24%
CURRENT VS 3Y AVG
-1237.11%
CURRENT VS 5Y AVG
-829.76%
CURRENT VS 10Y AVG
-776.94%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-498.12%
vs the sector median at left
MediWound Ltd.
Market Cap
$169.76M
Interest Coverage Ratio
-38.13x
TTM Avg
-4.58x
3Y Avg
-2.85x
5Y Avg
-4.10x
Market Cap
$169.85M
Interest Coverage Ratio
N/A
TTM Avg
8.41x
3Y Avg
7.29x
5Y Avg
7.29x
Market Cap
$170.21M
Interest Coverage Ratio
-74.29x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$171.68M
Interest Coverage Ratio
-36.67x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$165.81M
Interest Coverage Ratio
2.28x
TTM Avg
2.28x
3Y Avg
2.28x
5Y Avg
2.28x
Market Cap
$173.52M
Interest Coverage Ratio
-2.21x
TTM Avg
15.94x
3Y Avg
15.94x
5Y Avg
15.94x
Market Cap
$163.69M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$173.76M
Interest Coverage Ratio
-48.66x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MediWound Ltd. (MDWD) | $169.76M | -38.13x | -4.58x | -2.85x | -4.10x |
| Nkarta, Inc. (NKTX)vs › | $167.77M | N/A | N/A | N/A | N/A |
| Organogenesis Holdings Inc. (ORGO)vs › | $169.85M | N/A | 8.41x | 7.29x | 7.29x |
| Cue Biopharma, Inc. (CUE)vs › | $170.21M | -74.29x | N/A | N/A | N/A |
| Precision BioSciences, Inc. (DTIL)vs › | $171.68M | -36.67x | N/A | N/A | N/A |
| OptimizeRx Corp. (OPRX)vs › | $165.81M | 2.28x | 2.28x | 2.28x | 2.28x |
| Journey Medical Corporation (DERM)vs › | $173.52M | -2.21x | 15.94x | 15.94x | 15.94x |
| Quanterix Corporation (QTRX)vs › | $163.69M | N/A | N/A | N/A | N/A |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.76M | -48.66x | N/A | N/A | N/A |
| Coherus Oncology, Inc. (CHRS)vs › | $163.00M | -19.95x | 6.75x | 6.75x | 6.75x |
Interest Coverage
-38.1x
Debt/Equity
0.27
Current Ratio
2.32
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -8.44x |
| 2025-06-30 | -0.72x |
| 2024-09-30 | -0.98x |
| 2024-06-30 | -1.86x |
| 2024-03-31 | -0.63x |
| 2023-06-30 | -4.49x |
| 2022-12-31 | 0.21x |
| 2022-09-30 | -4.49x |
| 2022-06-30 | -5.35x |
| 2022-03-31 | -7.46x |
| 2021-12-31 | -5.54x |
| 2021-09-30 | -6.31x |
| 2021-06-30 | -7.26x |
| 2021-03-31 | -2.04x |
| 2020-09-30 | -2.85x |
| 2020-06-30 | -5.51x |
| 2020-03-31 | -4.47x |
| 2019-12-31 | -4.93x |
| 2019-09-30 | -7.00x |
| 2019-06-30 | 10.61x |
| 2019-03-31 | -5.57x |
| 2017-03-31 | -5.63x |
| 2016-03-31 | -18.12x |
| 2015-12-31 | -7.19x |
| 2015-09-30 | -12.68x |
| 2015-06-30 | -25.77x |
| 2015-03-31 | -2.79x |
| 2014-12-31 | -11.72x |
| 2014-09-30 | -9.82x |
| 2014-06-30 | -5.50x |
| 2014-03-31 | -5.65x |
| 2013-09-30 | -2.74x |
| 2013-06-30 | -1.09x |
| 2013-03-31 | -1.59x |
